Oxygenta Pharmaceutical Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Oxygenta Pharmaceutical Ltd. on BSE

Load latest

Oxygenta Pharmaceutical Ltd.

08 Feb 2025

70.45

-0.77%

Board Meeting

Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation …

BSE India

Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the company will be held on Friday, February 14, 2025, inter alia, to consider the Un-audited financial results of the Company for the Third quarter ended on December 31, 2024 pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015. In continuation to our earlier intimation of closure of trading window, we would like to inform that the trading window of the Company for all the designated persons and their immediate relatives will remain closed till February 16, 2025, which is 48 hours after the said Board Meeting. This is for your information and records.

pdf

Oxygenta Pharmaceutical Ltd.

06 Feb 2025

70.45

-0.77%

Company Update

Oxygenta Pharmaceutical Ltd - 524636 - Updates on Open Offer

BSE India

Mark Corporate Advisors Pvt Ltd. ("Manager to the Offer") has submitted to BSE a copy of Offer Opening Public Announcement under Regulation 18(7) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, for the attention of the eligible equity shareholders of Oxygenta Pharmaceutical Ltd ("the Company").

pdf

Oxygenta Pharmaceutical Ltd.

04 Feb 2025

70.45

-0.77%

Company Update

Oxygenta Pharmaceutical Ltd - 524636 - Recommendations of the Committee of ID under Reg 26(7) of …

BSE India

Independent Directors Committee (IDC) have submitted to BSE recommendations under Regulation 26(7) of SEBI (SAST) Regulations, 2011, for the Open Offer to Public Shareholders of Oxygenta Pharmaceutical Ltd.

pdf

Oxygenta Pharmaceutical Ltd.

31 Jan 2025

70.45

-0.77%

Company Update

Oxygenta Pharmaceutical Ltd - 524636 - Letter of Offer

BSE India

Mark Corporate Advisors Pvt Ltd. ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the eligible equity shareholders of Oxygenta Pharmaceutical Ltd ("the Company").

pdf

Oxygenta Pharmaceutical Ltd.

17 Jan 2025

70.45

-0.77%

Company Update

Oxygenta Pharmaceutical Ltd - 524636 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

The Certificate issued by the RTA dated 03.01.2025 attached herewith

pdf

Oxygenta Pharmaceutical Ltd.

27 Dec 2024

70.45

-0.77%

SAST

Oxygenta Pharmaceutical Ltd - 524636 - Closure of Trading Window

BSE India

Intimation of Closure of Trading window from 1st January 2025 till 48 hours from declaration of unaudited results for the quarter ending 31st December 2024

pdf

Oxygenta Pharmaceutical Ltd.

15 Nov 2024

70.45

-0.77%

Company Update

Oxygenta Pharmaceutical Ltd - 524636 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Un Audited results of Quarter ended 30th September 2024 published in the news paper.

pdf

Oxygenta Pharmaceutical Ltd.

14 Nov 2024

70.45

-0.77%

Result

Oxygenta Pharmaceutical Ltd - 524636 - Un Audited Results For Quarter Ended On September 30, 2024

BSE India

Board of Directors approved the Un Audited Results for the Half year and Second quarter ended on September 30, 2024.

pdf

Oxygenta Pharmaceutical Ltd.

07 Nov 2024

70.45

-0.77%

Board Meeting

Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation …

BSE India

Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the company will be held on Thursday, November 14, 2024, inter alia, to consider the Un-audited financial results of the Company for the Second quarter ended on September 30, 2024 pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015. In continuation to our earlier intimation of closure of trading window, we would like to inform that the trading window of the Company for all the designated persons and their immediate relatives will remain closed till November 16, 2024, which is 48 hours after the said Board Meeting. This is for your information and records.

pdf

Oxygenta Pharmaceutical Ltd.

22 Oct 2024

70.45

-0.77%

Corp. Note

Oxygenta Pharmaceutical Ltd - 524636 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Loss of share certificate intimation received from the company.

pdf

Is S S Organics Ltd. worth buying?

4 Votes:

Buy 75.0%

Sell 25.0%